Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Recombinant Proteins
Sort By
Newest First
1 / 1
1 / 1
Recombinant Proteins
The Expanding Role for Recombinant Proteins in Research
Rob Burgess, Ph.D.
Sino Biological
PAO-11-22-PATV-01
Jan 06, 2023
Recombinant Antibodies
Taking a Customer-Focused Approach to Custom Antibody Development and Manufacturing
Rob Burgess, Ph.D.; Amy Sheng, Ph.D.; Lilith Elmore
Sino Biological
PAO-04-022-CL-01
Apr 07, 2022
Recombinant Antibody Production
HEK Cells vs. CHO Cells in Recombinant Antibody Production: What's the Better Choice
evitria AG
PAO-03-022-CL-22
Mar 22, 2022
Recombinant Proteins
Meeting the Renewed Demand for Microbial Protein Production
Grifols Recombinant Protein CDMO
PAO-01-22-R250-07
Jan 28, 2022
Single-Use Technology
Facilitating Clinical Manufacturing of Recombinant Proteins with Large-Scale Single-Use Fermentation Technology
Scott Doncaster; Cameron Graham; Neil Morrison
BIOVECTRA
PAO-10-21-CL-08-778
Oct 20, 2021
M&A
Sovereign Backs the Bioscript Team to Expand the Business
Sovereign's Capital
PR-M06-21-012
Jun 04, 2021
Capacity Expansion
German CDMO Richter-Helm Triples cGMP Production Capacity to Accommodate Global Market Demand
Richter-Helm BioLogics
PR-M05-21-008
May 12, 2021
Recombinant Proteins
Innovation and Flexibility Drive Success During the COVID-19 Pandemic
Paul Magreta
Grifols Recombinant Protein CDMO
PAP-Q3-20-CL-019
Sep 29, 2020
Virtual Panel
Leveraging a Biomanufacturing Legacy to Support New Business
Grifols Recombinant Protein CDMO
PAP-Q1-20-CL-005
Mar 19, 2020
Analytical Development
Solving Process Challenges Requires Flexibility to Explore Alternative Analytical Methods
Shaonly Saha
Grifols Recombinant Protein CDMO
PAP-Q4-19-CL-017
Dec 06, 2019
Plant-Based
Proprietary Protein Therapeutics with Clinically Improved Profiles
Dror Bashan
Protalix BioTherapeutics
PAP-Q4-19-CL-028
Dec 06, 2019
Patient Enrollment
Inhibrx Announces Enrollment of First Patient in Phase 1 Study of INBRX-101, a Modified Recombinant Human AAT-Fc Fusion Protein
Inhibrx, Inc.
PR-M09-19-NI-023
Sep 10, 2019
Recombinant Proteins
New Facility Presents Manufacturing Solutions for Recombinant Proteins
Paul Magreta
Grifols Recombinant Protein CDMO
PAP-Q2-2019-CL-019
May 24, 2019
Plant-Based Solutions
Plant-based Protein Expression for Rapid, Green Bioprocessing
Robert Erwin
iBio, Inc.
PAP-Q2-2019-CL-022
May 24, 2019
